Carbamazepine is widely used in clinical practice for the treatment of patients with epilepsy, neuropathic pain, and bipolar disorder, but a small number of patients with HLA-B*1502 allele may experience serious adverse reactions after taking the drug. HLA-B*1502 genotyping is highly recommended before using carbamazepine.
Product Advantages
1、Recommended by the clinical guidelines
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
Target group
1、Epilepsy
2、Trigeminal neuralgia
3、Glossopharyngeal neuralgia
4、Schizophrenia
5、Central urogenital disorder
6、Manic depressive disorder
7、Alcohol withdrawal syndrome and other people
2、Trigeminal neuralgia
3、Glossopharyngeal neuralgia
4、Schizophrenia
5、Central urogenital disorder
6、Manic depressive disorder
7、Alcohol withdrawal syndrome and other people
